[Results of treating trophoblastic disease (based on data from the N. N. Petrov Research Institute of Oncology of the Ministry of Public Health of the USSR)].
D000328:Adult; D002822:Choriocarcinoma / Q000401:mortality / Q000601:surgery / Q000628:therapy; D003609:Dactinomycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D011247:Pregnancy; D012426:Russia; D013308:Streptonigrin / Q000627:therapeutic use; D013997:Time Factors; D014328:Trophoblastic Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D014594:Uterine Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy
D003609:Dactinomycin; D013308:Streptonigrin; D015122:Mercaptopurine; D008727:Methotrexate
Rezul'taty lecheniia bol'nykh trofoblasticheskoĭ bolezn'iu (po materialam NII onkologii im. prof. N. N. Petrova MZ SSSR)